Target Audience:

Hematologists-oncologists, oncologists, physician assistants, nurse practitioners, and oncology nurses involved in the care of patients with myeloma.

Learning Objectives:

Upon completing this activity, the participant will be able to:

• Describe the latest developments in myeloma, including current and emerging treatments
• Engage patients and caregivers in clinical trial discussions on newly approved therapies and emerging therapies for myeloma
• Identify strategies for optimal patient care
• Apply evidence-based treatment strategies

Agenda:

6:00 pm – 6:45 pm:    Dinner and networking

6:45 – 7:00 pm:           Welcome and introduction
                                       Cindy Varga, MD, FRCP  and Lauren Berger, MPH 

7:00 pm – 7:30 pm:    The role of vaccine therapy and CAR T treatment in relapsed/refractory multiple myeloma 
                                       Jacalyn Rosenblatt, MD, Thomas Garcia, MD, and Paul Richardson, MD 

7:30 pm – 8:00 pm:    AL Amyloidosis: The importance of accurate typing and appropriate treatment in the management                                        of AL amyloidosis
                                       Vaishali Sanchorawala, MD and Andrew Staron, MD

8:00 pm – 8:30 pm:    The current approach to treating bone disease in myeloma
                                Andrew J. Yee, MD and TBD

Sponsor:

This activity is supported by The Leukemia & Lymphoma Society

Providers:

Jointly provided by The Leukemia & Lymphoma Society and Medical Learning Institute, Inc.